Background: Alcohol use has been reliably associated with smaller subcortical and cortical regional gray matter volumes (GMVs). Whether these associations reflect shared predisposing risk factors and/or causal consequences of alcohol use remains poorly understood.
GMV represent promising biomarkers for alcohol consumption liability and related psychiatric and behavioral phenotypes.
INTRODUCTION
Alcohol use and its associated negative consequences are ubiquitous international public health concerns. Worldwide, the average person aged 15 or older consumes 6.2 liters of alcohol annually, and alcohol use accounts for 6% of deaths and 5% of disease burden (1) . Combined with the widespread prevalence of problematic alcohol use (e.g., alcohol use disorder lifetime prevalence = 29% (2); current month binge drinking = 26% of US adults (3)), these staggering public health consequences have led to extensive efforts to understand the impact of alcohol use on brain and behavior and identify markers of alcohol use liability.
Neuroimaging studies have consistently shown that alcohol consumption and use disorder are associated with smaller subcortical and cortical gray matter volumes (GMVs), particularly among regions that feature prominently in emotion, memory, reward, cognitive control, and decision making (4) (5) (6) (7) (8) (9) (10) . While there is evidence that these associations may arise as a consequence of drinking (e.g., reduced neurogenesis in non-human primate models, greater GMV decline among adolescents following initiation of heavy drinking, GMV normalization following abstinence among dependent individuals) (10) (11) (12) (13) (14) (15) (16) (17) , other data suggest that they may reflect preexisting vulnerabilities that precede and predict drinking initiation and escalating use (18) (19) (20) (21) (22) .
Here, using neuroimaging data from 3 samples (total n=2,423) (23) (24) (25) spanning childhood/adolescence to middle age with prospective or family-based data, we first identify replicable GMV correlates of alcohol use before testing whether these correlates: (1) are plausibly attributable to shared predisposing factors (e.g., shared genetic influence) and/or arise as a consequence from alcohol use, (2) prospectively predict future drinking in young adulthood, and (3) predict drinking initiation in adolescence. Finally, we examined whether genetic risk for
alcohol consumption is associated with genes and genetically-conferred differences in gene expression that are preferentially expressed in regions identified by neuroimaging analyses and/or the brain more generally using curated post-mortem data. Here, we applied gene-set enrichment, partitioned heritability, and transcriptome-wide (TWAS) (26) analyses to genomewide association study (GWAS) summary statistics from the UK Biobank (N=112,117) (27) and AlcGen/CHARGE+ (N = 70,460) (28) studies of alcohol consumption, and RNA-seq data from GTEX (N=81-103)(29) and the Common Mind Consortium (N=452) (30) .
METHODS AND MATERIALS

Participants
Neuroimaging data were drawn from three independent samples: the Duke Neurogenetics Study (DNS; n=1,303) (23), the Human Connectome Project (HCP; n=897) (24) , and the Teen Alcohol
Outcomes Study (TAOS; n=223) (25) that assessed a wide variety of behavioral, experiential, and biological phenotypes among young adult college students (DNS), young-middle aged adults (HCP), and children/adolescents (TAOS). The DNS and TAOS samples collected longitudinal data on alcohol use subsequent to the baseline scan. The family-based HCP sample is composed of twin and non-twin siblings. All studies followed protocols approved by relevant Institutional
Review Boards and remunerated participants. Additional information regarding each sample is provided in the Supplement.
Alcohol Use Assessment
Alcohol use in the DNS was assessed at baseline (past 12 month use) and follow ups (questions modified to reflect use following the prior assessment) using the Alcohol Use Disorders using questions from Semi-Structured Assessment for the Genetics of Alcoholism (SSAGA) (33) and Substance Use Questionnaire (SUQ) (34), respectively. Importantly, the aAUDIT-C for the HCP used maximum lifetime data so that these data could be used to estimate genetic influences.
In TAOS, the initiation of alcohol use was defined as attaining a score of 1 or greater on the aAUDIT-C (i.e., participant reports consuming at least one full alcoholic beverage; N=82 
Covariates
The following variables known to be correlated with alcohol consumption/GMV were included as covariates in all analyses: age(35-37), sex (36) (37) (38) (39) , ethnicity (39, 40) , socioeconomic status (SES) (35) (36) (37) (38) (39) , as well as early-life and recent-life stress (41) (42) (43) and intracranial volume (ICV).
In samples where multiple scanners were used, scanner was also included as a covariate. In adult samples (DNS, HCP), the presence of any non-substance Axis-I DSM-IV psychiatric disorder was included as a covariate. As the TAOS sample was composed of children/adolescents enriched for a family history of depression, tanner stage and depressive symptoms were included as covariates in all analyses. The Supplement contains additional details.
Magnetic Resonance Imaging Processing
Acquisition parameters and GMV processing for each study are detailed in the Supplement.
Statistical Analyses
Discovery: A whole-brain voxel-based morphometry GLM regression analysis was conducted using SPM12 in the DNS sample to test whether alcohol consumption (AUDIT-C) is associated with differences in GMV. Covariates included sex, age, self-reported race/ethnicity (i.e., notwhite/white, not-black/black, not Hispanic/Hispanic), scanner id (two identical scanners were used), intracranial volume (ICV), presence of a diagnosis other than alcohol or substance abuse or dependence, perceived stress (PSS), parental education (P-ED), early-life stress (CTQ), and
perceived economic status (P-SES). Analyses were thresholded at p<0.05 FWE with a cluster extent threshold of 10 contiguous voxels (k e =10) across the entire search volume.
Replication: Replication analyses in the HCP sample examined whether lifetime maximum alcohol consumption (aAUDIT-C) predicted differences in GMV only within regions of interest (ROIs) where associations were observed in the discovery DNS sample (Figure 1 , Supplemental Table 1 ). ROIs were defined by the AAL atlas (44) . A voxelwise GLM regression limited to these ROIs was conducted using multi-level block permutation-based nonparametric testing (FSL PALM v.alpha103; tail approximation p<0.10 with 5,000 permutations), which accounts for the family-structure of the HCP data while correcting for multiple comparisons across space (45) (46) (47) 
Post-hoc Analyses
Total anatomical ROI GMV of regions associated with alcohol use in both the DNS and HCP (i.e., right Insula and Middle/Superior Frontal Gyrus; see Results) were extracted from both datasets for post-hoc analyses. Total volumes were used so that effect sizes would not be inflated by selecting only voxels that were specifically associated with the outcome of interest (48) . 
Discordant twin analysis:
Following evidence that alcohol consumption is co-heritable with volume of the right insula and middle/superior frontal gyri (see Results), we examined whether same-sex twin and non-twin sibling pairs discordant for alcohol consumption differed from each other on brain volume in HCP. These analyses examined whether aAUDIT-C was associated with insular or middle/superior frontal volume after accounting for sibling-shared genetic background and experience. Same-sex siblings were considered "high alcohol consumers" or "low alcohol consumers" if their aAUDIT-C score was greater than 0.5 SD above the sample mean (aAUDIT-C > 4.67, or less than 0.5 SD below the sample mean (aAUDIT-C < 1.54),
respectively. Concordant sibling-pairs were defined as a pair who were both in the same category of consumption (i.e. high or low), and additionally scored within 1 SD of each other (low alcohol concordant pairs: n=117; aAUDIT-C M=0.84, SD=0.77; high alcohol concordant pairs: n=54; B a r a n g e r e t a l . ,
aAUDIT-C M=0.84, SD=0.77). There were 72 discordant sibling pairs ("low discordant";
aAUDIT-C M=1.25, SD=0.73; "high discordant"; aAUDIT-C M=6.47, SD=1.67). Participants could be included in more than one pair (N=368 individuals) when considering relationships with multiple siblings. Discordancy analyses were conducted using linear mixed models, as sibling pairs are non-independent, using the 'Psych' (51) and 'lme4' (52) packages in R (53) between observations. The model included both random intercept and random slope components, with a continuous autoregressive correlation structure. Time was coded as both linear and quadratic age at the date of response (baseline or follow-up). Models tested the interaction between brain volume and age (i.e. does baseline ROI volume predict a different slope of change in drinking behavior as participant's age?). Covariates were Z-scored, and were identical to neuroimaging analyses, with the addition of second-order interactions between covariates and primary variables (57, 58) . Each of the two ROIs were tested in separate models, and p-values were FDR corrected (i.e., 4 tests -middle/superior x linear-age, middle/superior x quadraticage).
DNS longitudinal changes in alcohol consumption
TAOS longitudinal initiation of alcohol use:
The R 'lme4 package (59) was used to fit a longitudinal logistic multilevel model, which tested whether baseline brain volume in nondrinking adolescents predicted future initiation of alcohol use. The model included both random intercept and random slope components, and time was coded as both the linear and quadratic age at the date of response. The model tested the interaction between GMV and age (i.e. does B a r a n g e r e t a l . , 
SNP-Based Enrichment:
We tested whether the SNP-based heritability of alcohol consumption is enriched in brain-expressed gene-sets, and whether this enrichment is specific to any region.
Stratified LD-score regression (60-62) was applied to summary statistics from the genome-wide association study of alcohol consumption in the UK Biobank (N=112,117) (27) . Tissue-enriched gene-sets, provided by the Alkes Group, were generated using data from the GTEx Consortium (29). In this analysis, a gene is assigned to a gene-set if it shows greater enrichment in that tissue than 90% of genes. Gene-sets for brain regions were generated both by comparing each region to all non-brain tissues, and by comparing each brain region to all other regions. It was further tested whether genetic associations with alcohol consumption are enriched in brain-expressed gene-sets using MAGMA (63), implemented through FUMA (64).
Transcriptome-Wide Analysis (TWAS):
Following evidence that genetic associations with alcohol consumption are enriched in brain-expressed gene-sets, and that the SNP-based heritability of alcohol consumption is enriched in these gene-sets, we tested whether genetic risk B a r a n g e r e t a l . ,
for alcohol consumption is predictive of changes in post-mortem gene expression in regions identified in our neuroimaging analyses and the human brain more generally. Pre-computed gene-expression RNA-seq weights for nine brain regions and the liver from GTEX (29) were analyzed using the FUSION suite (26) . We tested whether genetic risk for alcohol consumption, as determined by the results from the UK Biobank GWAS (27) , is associated with differential RNA expression. Results were bonferroni-corrected for n=9,839 tests across the ten tissues.
Replication was tested using independent GWAS data from an earlier non-overlapping study of alcohol consumption (N = 70,460) (28) and computed gene-expression weights for the dorsolateral prefrontal cortex from the CommonMind Consortium (30) . As the gene that showed the strongest association in the discovery dataset was not present in the replication data, we examined whether any of the gene-expression associations at p-fdr<0.05 in Brodmann Area 9
were significant in the replication data (see Results). Any identified genes, were probed for association with other phenotypes in prior GWAS using PheWAS within the GWAS ATLAS (http://atlas.ctglab.nl/). Brodmann area 9 in the GTEx dataset and DLPFC in the CommonMind consortium dataset overlap with the prefrontal regions implicated in our neuroimaging analyses (i.e., superior and middle frontal gyri; see Results). No postmortem insula data were available.
RESULTS
Whole brain discovery analyses in DNS revealed that greater alcohol consumption is associated
with lower GMV across 8 clusters (Figure 1 ; Table 1 ), encompassing regions identified in prior studies of unselected samples (5, 17) and among individuals with alcohol use disorder (4, 6). The associations with two of these clusters (right insula, right superior/middle frontal gyrus)
replicated within an ROI analysis in the HCP (Figure 1 ; Table 1 ). Statistics are presented in Tables and Figure legends 
gyrus GMV predicted the initiation of alcohol use at an earlier age in those who were nondrinkers at baseline ( Figure 3B&C ; Supplementary Table 4) .
Gene-based association and partitioned heritability enrichment analyses of the UK Biobank GWAS of alcohol consumption revealed enrichment only among brain gene-sets.
Moreover, Brodmann Area 9, which overlaps with the frontal region in which we observed a replicated negative association between GMV and alcohol consumption that is attributable to shared genetic influence and predictive of drinking initiation, was among the regions with strongest enrichment (Figure 4 , Supplemental Data). A transcriptome-wide association study (TWAS) analysis of these GWAS data similarly found that genetic risk for alcohol consumption was significantly associated with differences in gene expression across the brain within the GTEx dataset, including C16orf93 within Brodmann Area 9 ( Figure 5 ; Table 2 ). Other identified genes include CWF19L1 in the putamen and cortex, AC074117 in the cerebellum, and C1QTNF4 in cortex ( Figure 5) . C16orf93 was not available in the TWAS replication dataset (i.e., (28) and the CommonMind Consortium (30) dataset; Table 2 ). Three additional genes (i.e.,
CW19L1, PHBP9, C18orf8) were associated with genetically-related differential expression in
Brodmann Area 9 that survived FDR correction in the discovery dataset (i.e., across all tissues tested), two of which (i.e., CW19L1 and C18orf8) were available in the TWAS replication dataset ( Figure 5 ; Table 2) 2 . Genetically-related expression of CWF19L1 and C18orf8, within the DLPFC of our TWAS replication dataset were related to genomic risk for alcohol consumption in the same direction as observed in the discovery dataset, and survived fdrcorrection for multiple comparisons ( Table 2) . Notably, genetic risk for alcohol consumption was not significantly associated with the expression of any gene in the liver (Figure 5) 
using the GWAS ATLAS revealed evidence that both CWF19L1 and C18orf8 have been implicated in a host of phenotypes, including psychiatric conditions and related traits such as executive function, schizophrenia (CWF19L1), and substance use (C18orf8; Supplemental Data).
An examination of putative behavioral mediators available in the DNS and HCP (i.e., executive function, delay discounting, self-reported impulsivity, negative urgency, and neuroticism) that might mediate links between brain structure and alcohol consumption were tested for association with GMV. Despite nominally significant associations between delayeddiscounting and IQ, and GMV of the right frontal cortex in the DNS, none of these associations replicated within the HCP data or were robust to multiple testing correction (see Supplement;
Supplemental Tables 9-10) .
DISCUSSION
We report convergent evidence that smaller right insula and DLPFC (i.e., middle and superior frontal gyri) GMVs plausibly represent genetically-conferred liabilities that promote early alcohol use. First, we show that smaller GMV of the right insula and DLPFC were replicably associated with alcohol use in two large neuroimaging samples. Second, family-based data provide evidence that these associations are attributable to shared genetic factors with no evidence that environmental factors contribute to this association. Third, reduced DLPFC volume prospectively predicted future alcohol use among young adults as well as alcohol use initiation during adolescence among children/adolescents who were unexposed to alcohol at baseline. Finally, we find replicable evidence that genomic risk for alcohol use is enriched among genes preferentially expressed within the DLPFC, and that genomic liability to alcohol use is associated with differential expression of C16orf93, CWF19L1, C18orf8 in the DLPFC.
Collectively, these convergent data suggest that lower GMV in middle/superior frontal gyri and insula may represent a preexisting genetic liability for drinking that could serve as a prognostic biomarker. Further, these data suggest the alcohol use in the general population does not induce reductions in GMV, at least as measured using MRI, as has been previously hypothesized (5, 8, 10) . It is possible that reduced GMV in the superior and middle frontal gyri and insula may promote alcohol use, increasing the likelihood of heavy use, which may then further potentiate GMV loss in these regions and others (10, 15, 16) .
A few notable points within our data require additional interpretation. First, in the longitudinal child/adolescent sample of baseline non-users (i.e., TAOS) we find that DLPFC GMV prospectively predicts an early age of drinking initiation. In the DNS longitudinal prospective data of young adults, reduced GMV in these regions also predicted future alcohol
use, even after accounting for the extent of baseline alcohol use. However, this was only predictive up until age 20.85. It is possible that risk conferred by reduced GMV in the DLPFC is developmentally constrained and/or may be minimized by environmental differences in permissivity/legality, as the legal drinking age in the United States is 21 (65) .
Second, we find no compelling evidence that behaviors speculated to contribute to alcohol use (e.g., executive function, negative urgency, and impulsivity) are associated with prefrontal or insula GMV, leaving the behavioral mechanisms through which these GMVs influence alcohol use unclear. That DLPFC GMV was negatively correlated with delay discounting and using alcohol to cope with stress in our young adult sample (DNS) at nominal levels of significance, while being unlinked in our young/middle aged adult sample (HCP;
Supplementary Tables 9&10), is consistent with potentially developmentally constrained effects.
Third, genomic risk for alcohol use was enriched only within brain gene-sets. Brodmann Area 9, which overlaps with the DLPFC regions identified in our neuroimaging analyses was among the regions of strongest enrichment (Figure 4) . Further, TWAS analyses revealed replicable evidence that genomic risk for alcohol use is associated with differential expression of CWF19L1 and C18orf8 within these regions. The function of these genes is not understood. Both 
Finally, given evidence that genetic liability is shared across substance use involvement While our study is limited by our sample size, particularly of discordant twins and longitudinal analyses, a major strength of our results is the convergent evidence provided by the different study designs (72) . We note that our cross-sectional analyses of alcohol consumption and longitudinal analyses of adolescent use initiation, are the largest to-date that we know of. A primary limitation of our gene-expression analyses is that both of the gene-expression datasets included alcohol-exposed donors. Given the wide prevalence of alcohol use across the world (73), it will likely be impossible to ever definitively confirm in human adults that alcohol use is not confounding these results. Notably, none of the identified genes (C16orf93, CWF19L1, C18orf8) have been found to be differentially expressed in the frontal cortex of donors with alcoholism (74, 75) . Our analyses are also limited by the omission of the insula from the geneexpression data, precluding a comparison of the gene-expression correlates between the insula and frontal cortex.
Limitations notwithstanding, our study provides convergent evidence that smaller GMV in the insula and DLPFC associated with alcohol use may represent a genetically-conferred
liability that promotes early alcohol use. While this may in turn lead to accelerated volume loss within these and other regions, these findings challenge predominant interpretations that smaller brain volumes tied to alcohol use emerge primarily from the atrophy-inducing effects of alcohol.
As larger prospective samples are acquired (e.g., ABCD), it will be interesting to test influential theories of substance use liability, and to examine the interplay of genetic risk and substance-use on the trajectories of brain development.
Data Availability
All data pertaining to this study are available upon request to the corresponding author. 
Identification of risk loci with shared effects on five major psychiatric disorders: a genomewide analysis. Statistical parametric map illustrating regions of reduced brain volume associated with increased alcohol consumption (Supplemental Table 1 ), overlaid onto a canonical structural brain image Montreal Neurological Institute coordinates and statistics (DNS: p<0.05, family-wise error whole-brain corrected, ≥ 10 contiguous voxels; HCP: p<0.05, family-wise error region-of-interest corrected, ≥ 10 contiguous voxels). Alcohol consumption was not associated with increased volume in any region. Notably, in the HCP dataset, the superior frontal gyrus cluster extended into the right middle frontal gyrus, and was located relatively far (34 mm dorsal) from the original right superior frontal cluster identified in DNS. In contrast, this peak in the HCP was located 11.6 mm away from the right middle frontal peak identified in the DNS. Thus, for the purposes of post-hoc analyses, the combined volume of both the right middle and superior frontal gyrus cortices was extracted from both samples. Table  1 ). B) Significant phenotypic correlations between aAUDIT-C scores and volumes of the right insula and middle/superior frontal gyri are attributable to shared genetic (Insula: -0.2314, p=0.0022; Frontal: -0.2192, p=0.0054), but not environmental factors (Supplemental Table 1 ). C&D) Distribution of (C) right insula and (D) right middle/superior frontal volumes by alcohol exposure group. High = aAUDIT-C score > sample mean + 0.5 SD (i.e. > 4.67); Low =
aAUDIT-C score < sample mean -0. Table 4 ). Analyses were conducted with continuous data; partitioned into three equally-sized groups according to volume was done for display-purposes only. 
Figure 4: Tissue-specific Enrichment of Alcohol Consumption Genomic Risk
Enrichment of alcohol consumption GWAS (UK Biobank, N=112,117) A) associations and B&C) heritability, in gene-sets defined by the relative expression of genes across A&B) all tissues, and C) within the brain, in the GTEX data set (Supplemental Data). X-axis and colorscale represent the significance of the enrichment (-log-scale of the p-value). Solid, dashed, and dotted lines represent Bonferroni-corrected, FDR-corrected, and nominally significant p-values, respectively.
Figure 5: TWAS of alcohol consumption predicting gene expression
Genetic risk for alcohol consumption according to the UK Biobank GWAS (N=112,117) is associated with differences in human post-mortem gene expression (GTEx; Ns = 81 -103), including frontal cortex BA9 (Supplemental Data). Notably, associations in the liver (far right) do not survive bonferroni-correction for multiple comparisons, though four are significant at a less-stringent FDR-based correction. Y-axis represents the significance of the association. Solid, dashed, and dotted lines represent Bonferroni-corrected, FDR-corrected, and nominally significant p-values, respectively. 
